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Abstract
Background: Takayasu's arteritis is a chronic systemic inflammatory disease that usually affects
the aorta, its primary branches and occasionally the pulmonary and coronary arteries. Female
gender in reproductive age and Asian origin are known factors associated with higher disease
prevalence. The clinical manifestations vary considerably and are typically caused by limb or organ
ischemia illness and fever. The estimated incidence rate in the western world is 2.6 cases per million
persons per year. Occasionally, exertional dyspnea can be the sole primary clinical manifestation of
Takayasu's arteritis.
Case presentation: We report the case of a 57-year-old woman who was referred to our
institution with increasing exertional dyspnea caused by pulmonary artery involvement in
Takayasu's arteritis. In a review of the literature we discuss demographic data, clinical and
radiographic findings and available therapeutic options.
Conclusions: Dyspnea due to pulmonary artery involvement can be the initial symptom of
Takayasu's arteritis. Simple clinical tests, including a complete pulse-status and blood pressure
measuring at both arms can lead to the right diagnosis and should always be done beyond the
auscultation of the heart and lungs in patients with dyspnea.
Background
Diagnosis of Takayasu's arteritis is always challenging as
the clinical presentation may vary considerably. Especially
pulmonary artery involvement is difficult to differentiate
from chronic thromboembolic disease since progressive
dyspnea on exercise; chest pain and hemoptoe are the
most frequent symptoms [3]. A Takayasu arteritis may
also mimic idiopathic inflammatory diseases such as Be-
hçet's syndrome, giant cell arteritis and sarcoidosis or in-
fections (e.g. tuberculosis, syphilis). Since inherited
vascular diseases and fibromuscular dysplasia may
present similarly, they also have to be considered [4].
In 1990, the American College of Rheumatology suggest-
ed a set of criteria for the diagnosis of Takayasu's arteritis.
The criteria consist of (a) age <40 years, (b) claudication
of an extremity, (c) decreased brachial artery pulse, (d) >
10 mmHg difference in systolic pressure between the left
and right arm, (e) a bruit over subclavian arteries or aorta
and (f) angiographic evidence of narrowing or occlusion
of the aorta or its primary or proximal branches [5]. Pres-
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ence of three of the six criteria is required for the diagno-
sis. Our patient fulfilled four of those six.
The median age of patients with pulmonary manifestation
in the reviewed articles [3,10–28] was 35 years; eight of 32
patients screened were older than 40 years. This contrasts
with the reported median age (25–30 years) at onset of
Takayasu's arteritis [1,4]. It appears, that the average age at
disease onset is higher in patients with pulmonary mani-
festation as initial localization. We therefore suggest, that
the diagnostic criteria for Takayasu's arteritis of the Amer-
ican College of Rheumatology should be adapted accord-
ingly. The age criterion could be abandoned but coronary
or pulmonary artery involvement should be considered.
The most common clinical manifestation of Takayasu's
arteritis is the affection of the aorta and its main branches
[1]. But the involvement of the pulmonary arteries is also
well known. Recent articles described pulmonary artery
involvement in 14% to 86% of all cases with Takayasu's
arteritis [6–9]. However, there are only a few cases pub-
lished, where a Takayasu's arteritis initially presented with
pulmonary symptoms as seen in our patient.
In a literature review [3,10–28,34] of the last 10 years we
found 33 cases of Takayasu's arteritis in which symptoms
relating to pulmonary artery involvement occurred as the
initial clinical manifestation. An exclusive involvement of
the pulmonary artery with normal aortic angiography,
computer tomography or magnetic resonance imaging
was described in 11 of 33 cases; in one case confirmed by
histological examination. Summarizing the published lit-
erature, isolated pulmonary arteries involvement occurs
in about a third of all patients. This figure may be an over-
estimate since none of the cases documented a follow up.
Therefore a later affection of the aorta could not be ex-
cluded.
In our case we identified the involvement of both pulmo-
nary arteries. There was also MRI evidence of systemic ar-
terial involvement. The distribution of pulmonary
affection in the reviewed cases was unequal. In seventeen
of the thirty-three cases an affection of the right pulmo-
nary artery was described, in eleven cases both pulmonary
arteries were affected, whereas left pulmonary artery in-
volvement was reported once. The predominant role of
the right pulmonary artery was described also elsewhere
[6–9].
In Takayasu's arteritis systemic-pulmonary shunts are well
known. In the reviewed cases we found five coronary-pul-
monary, seven broncho-pulmonary and two other sys-
temic-pulmonary shunts. Such artery shunts appear to be
indicative of extensive pulmonary artery involvement [9].
Even though Takayasu's arteritis is more common in
Asian countries, the pulmonary artery involvement has
not shown any racial or geographic predilection [6]. In the
reviewed cases the female to male ratio was 6.5. Although
women of reproductive age may typically be affected (fe-
male to male ratio 8.5), recent reports confirm an in-
creased frequency in males [4]. The histology commonly
describes three lesions: (a) the classic large-vessel granulo-
matous giant cell arteritis which is similar to the his-
topathological findings in the aorta and its branches, (b)
a vessel-in-vessel disease, which appears to be an organ-
ized thrombus with newly formed endovascular arteri-
oles, these vessels may be formed from the vasa vasorum
and are branches of the bronchial artery, and (c) a dilation
of small blood vessels. It is unclear whether the dilation is
a plexogenic arteriopathy of high-grade pulmonary hyper-
tension or if this represents a Takayasu's arteritis of the
small arteries [3,17].
Morbidity results from arterial stenosis and aneurysms,
which may lead to aortic regurgitation and myocardial in-
farction, retinopathy or mesenteric vascular insufficiency
as well as claudication, renovascular hypertension stroke,
and increased pulmonary pressure with dyspnea on exer-
tion. Our patient reported breathlessness already at light
activity. In actual practice, the major functional classifica-
tions of patients with dyspnea are based on the degree of
exertion. However, in assessing the severity of dyspnea
variables like the patient's general physical condition and
interindividual variation in perception have to be consid-
ered. Some useful tests in diagnosing and quantification
of dyspnea are timed distance tests (i.e. 6- or 12-minute
walk) or cardiopulmonary exercise tests. Reported predic-
tors for morbidity and mortality are hypertension, cardiac
involvement aneurysms and retinopathy. Mortality is low
with five-year and ten-year survival rates between 70%
and 100%. Major causes of death are congestive heart fail-
ure and cerebrovascular complications [1,2,33].
Major complications that lead to an increased morbidity
are haemoptysis, severe congestive heart failure, pleural
effusion, cavitations with chronic inflammation and pul-
monary thrombembolism. Three of 33 patients died, two
due to massive haemoptysis and one as a result of postop-
erative complication after aortic aneurysm resection.
First line Therapy of Takayasu's arteritis is an immunosup-
pressive treatment primarily with corticosteroids. With
glucocorticoid treatment remissions occur in 40–60% of
all patients. About 40% of all steroid-resistant patients re-
spond to the addition of cytotoxic agents. Approximately
20% of all patients are resistant to any kind of therapy
[1,2,31]. Methotrexate appears to be a viable alternative
immunosuppressive agent whereas cyclophosphamide
treatment should be carefully considered because of sub-
stantial risk of toxicity. Hoffmann et al. showed thatBMC Pulmonary Medicine 2001, 1 http://www.biomedcentral.com/1471-2466/1/3
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methotrexate apparently induced or facilitated remissions
in 13 of 16 patients in whom treatment with glucocorti-
coids, and in some cases cytotoxic agents, had previously
failed [32].
Response to treatment may not be easily determined dur-
ing follow up. Clinical findings alone are no good disease
parameters and the ability to objectively measure disease
activity is limited. There is no known serological test, CRP
and ESR may be used to differentiate between active and
inactive disease status [29]. MRI and CT can visualize the
increased vascularisation in the thickened aortic wall. This
may indicate active stage of Takayasu's arteritis. In this sit-
uation MRI or CT can be used as an auxiliary marker for
disease activity [30]. Under therapy a decreased activity
was demonstrated by MR-angiography in our case, show-
ing reduction of the gadolinium uptake and in addition
lung perfusion scan confirmed an increase in the per-
fusion of the left lung.
Case presentation
A 57-year-old housewife was admitted to our department
because of dyspnea. A slight dyspnea on exertion started
years ago and deteriorated within the last few months
leading to shortness of breath at low physical activity. The
only associated symptom was an inconstant dry cough.
There was no history of former heart or pulmonary prob-
lems and the patient didn't take any medication. Indica-
tive for diagnosis was the clinical finding of decreased
right radialis pulse and a substantial difference in systolic
blood pressure between the left and right arm (130/100
mm Hg in the right arm and 160/ 90 mmHg in the left
arm). The pulse rate was 80 beats per minute. The clinical
examination further revealed systolic vascular bruits over
the 2nd intercostal space on the right, over both subclavi-
an and carotid arteries and over the abdominal aorta. The
laboratory findings only showed a slightly elevated eryth-
rocyte sedimentation rate (ESR) (30 mm/h) and a moder-
ately increased C-reactive protein level (CRP) (36 mg/l)
with normal differential blood count. An initial ECG,
chest radiograph and lung function tests were normal. The
echocardiographical result of a mild aortic regurgitation
could not explain the mentioned symptoms. Doppler-
sonography showed an osteal stenosis of the brachio-
cephalic trunk with a Ap max. of 32 mmHg. A magnetic
resonance angiography (MRA) scan of the chest and neck
showed an inflammation around the aortic arch, the su-
praaortal branches and the central pulmonary artery ves-
sels. In addition, the aortic wall was thickened and
concentric stenosis of the brachiocephalic trunk, the left
common carotid artery and the proximal pulmonary ar-
teries predominantly on the left side was found (fig. 1).
Lung perfusion scan showing homogeneous decrease of
radioisotope uptake of the entire left lung best explained
the exertional dyspnea. The calculated relative uptake ra-
tio of the right lung compared to the left was 3.65.
The combination of clinical findings, laboratory results
with slightly increased inflammatory parameters and the
typical radiological changes diagnosed a Takayasu's arteri-
tis with main involvement of the pulmonary arteries. Oth-
er differential diagnoses that were considered and
therefore excluded were Wegener's granulomatosis, giant
cell arteritis, Behçet disease, sarcoidosis, neoplastic disor-
ders and systemic infectious diseases. Involvement of the
renal artery that was suspected because of an abdominal
systolic bruit could be ruled out in duplex sonography.
We started an immunosuppressive therapy with pred-
nisone (1 mg per kg once daily). Under this treatment the
inflammatory parameters normalized within a month
and the exertional dyspnea almost fully regressed within
two months. Objective measurement of the patient's work
capacity was not obtained before and after treatment. As a
consequence of the systemic corticosteroids the patient
Figure 1
MR-angiography of the chest and neck showing concentric
stenosis of the brachiocephalic trunk, the left common
carotid artery and the proximal pulmonary arteries predomi-
nantly on the left side.BMC Pulmonary Medicine 2001, 1 http://www.biomedcentral.com/1471-2466/1/3
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felt nervous, gained 7 kg of weight and developed hyper-
tension.
Decreased activity of the disease was verified with MR-an-
giography that showed a reduction of the perivascular
gadolinium uptake. In addition, lung perfusion scan con-
firmed an increase of left lung perfusion with a right to left
ratio of 2,03 (fig. 2B). After four months administration of
corticosteroids, treatment was combined with methotrex-
ate 15 mg (i.m.) on a weekly basis. Consequently the
prednisone dosage could be reduced to 5 mg/day. Up to
now no side effects relating to the methotrexate therapy
have appeared. A control MRA under a combined immu-
nosuppressive treatment confirmed a further decrease of
the inflammatory process.
Conclusion
Dyspnea due to pulmonary artery involvement can be the
initial symptom of Takayasu's arteritis. Simple clinical
tests, including a complete pulse-status and blood pres-
sure measuring at both arms can lead to the right diagno-
sis and should always be done beyond the auscultation of
the heart and lungs in patients with dyspnea.
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